Go Pro

Hims & Hers Health (HIMS) Stock Price, News & Analysis

Hims & Hers Health logo
$28.85 -0.45 (-1.53%)
As of 12:21 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About Hims & Hers Health Stock (NYSE:HIMS)

Advanced

Key Stats

Today's Range
$28.55
▼
$30.61
50-Day Range
$24.97
▼
$33.67
52-Week Range
$13.74
▼
$65.30
Volume
4.83 million shs
Average Volume
23.64 million shs
Market Capitalization
$6.73 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$32.43
Consensus Rating
Hold

Company Overview

Hims & Hers Health, Inc. is a direct-to-consumer telehealth company that provides access to personalized healthcare through its online platforms, Hims and Hers. The company connects consumers with licensed healthcare professionals for virtual consultations, treatment plans and prescription medications where appropriate.

Its services address a range of common health and wellness needs, including sexual health, hair loss, skincare, mental health, weight management and primary care. Hims & Hers offers branded and generic treatments, over-the-counter products, supplements and personal-care products, with services designed for both men and women.

The company was founded in 2016, launched the Hims brand in 2017 and introduced the Hers brand in 2018. Hims & Hers Health became a publicly traded company in 2021 following a business combination with a special purpose acquisition company. Its platform primarily serves consumers in the United States, with an expanding international presence.

Andrew Dudum, a co-founder of the company, serves as chief executive officer. Hims & Hers Health combines digital health technology, clinician networks, pharmacy services and consumer-focused products to provide a more convenient alternative to traditional healthcare access.

AI Generated. May Contain Errors.

Hims & Hers Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
46th Percentile Overall Score

HIMS MarketRank™: 

Hims & Hers Health scored higher than 46% of companies evaluated by MarketBeat, and ranked 628th out of 892 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Hims & Hers Health has received a consensus rating of Hold. The company's average rating score is 2.13, and is based on no strong buy ratings, 3 buy ratings, 12 hold ratings, and 1 sell rating.

  • Upside Potential

    Hims & Hers Health has a consensus price target of $32.43, representing about 13.4% upside from its current price of $28.60.

  • Amount of Analyst Coverage

    Hims & Hers Health has been the subject of 11 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Hims & Hers Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Hims & Hers Health are expected to grow in the coming year, from ($0.16) to $0.44 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Hims & Hers Health is -45.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Hims & Hers Health is -45.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Hims & Hers Health has a P/B Ratio of 12.02. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Hims & Hers Health's valuation and earnings.
  • Percentage of Shares Shorted

    25.71% of the float of Hims & Hers Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Hims & Hers Health has a short interest ratio ("days to cover") of 6.13.
  • Change versus previous month

    Short interest in Hims & Hers Health has recently decreased by 3.69%, indicating that investor sentiment is improving.
  • Dividend Yield

    Hims & Hers Health does not currently pay a dividend.

  • Dividend Growth

    Hims & Hers Health does not have a long track record of dividend growth.

  • News Sentiment

    Hims & Hers Health has a news sentiment score of 0.07. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.49 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 46 news articles for Hims & Hers Health this week, compared to 9 articles on an average week.
  • Search Interest

    Only 46 people have searched for HIMS on MarketBeat in the last 30 days. This is a decrease of -8% compared to the previous 30 days.
  • MarketBeat Follows

    21 people have added Hims & Hers Health to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Hims & Hers Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,731,869.00 in company stock.

  • Percentage Held by Insiders

    11.76% of the stock of Hims & Hers Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    63.52% of the stock of Hims & Hers Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Hims & Hers Health's insider trading history.
Receive HIMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hims & Hers Health and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HIMS Stock News Headlines

They're not buying gold. They're buying this.
Bank of America raised its stake in a small gold company by 139%. Jane Street increased its position by 159%, and Millennium by 122%. Kopernik Global made it their largest holding, owning roughly 8% of the company. It holds rights to an 88 million ounce deposit with existing roads, power, and permits that never expire. Market cap sits near $4 billion against a deposit worth hundreds of billions at current gold prices.tc pixel
Laptop displaying the Hims & Hers logo beside a gavel, pill bottle, and declining stock chart with the US Capitol.
Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks
Hims & Hers Health shares fell 6.7% amid an FTC lawsuit over privacy and billing practices, a new securities class action, and a Q2 earnings miss that has weighed on the stock in 2026.
Digital screen displaying an upward-trending green candlestick stock chart with volume bars, set against blurred market charts.
Is the Market Right or Wrong About These 4 High Short Interest Stocks? (HIMS)
HIMS, ONDS, COIN, and SOFI show elevated short interest, but days-to-cover ratios, institutional ownership, and upcoming earnings reports suggest differing outlooks for short sellers.
Hims & Hers Health (NYSE:HIMS) CFO Sells 12,313 Shares
See More Headlines

HIMS Stock Analysis - Frequently Asked Questions

Hims & Hers Health's stock was trading at $32.45 at the beginning of the year. Since then, HIMS stock has decreased by 11.9% and is now trading at $28.5990.

Hims & Hers Health, Inc. (NYSE:HIMS) released its quarterly earnings results on Monday, August, 10th. The company reported ($0.37) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.05) by $0.32. The business's revenue for the quarter was up 38.2% on a year-over-year basis.
Read the conference call transcript
.

Hims & Hers Health's Board of Directors authorized a share buyback program on Monday, November 17th 2025, which authorizes the company to buy back $250,000,000 in outstanding shares, according to EventVestor. This means that the company could reacquire up to 3% of its shares through open market purchases. Shares buyback programs are typically an indication that the company's leadership believes its shares are undervalued.

Shares of HIMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Hims & Hers Health investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX) and Palo Alto Networks (PANW).

Company Calendar

Last Earnings
8/10/2026
Today
10/02/2026
Next Earnings (Estimated)
11/09/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Services
Current Symbol
NYSE:HIMS
CIK
1773751
Fax
N/A
Employees
2,442
Year Founded
2017

Price Target and Rating

High Price Target
$60.00
Low Price Target
$23.00
Potential Upside/Downside
+13.1%
Consensus Rating
Hold
Rating Score (0-4)
2.13
Research Coverage
16 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.63)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$128.37 million
Net Margins
-5.51%
Pretax Margin
-6.35%
Return on Equity
-6.51%
Return on Assets
-1.20%

Debt

Debt-to-Equity Ratio
4.21
Current Ratio
0.93
Quick Ratio
0.87

Sales & Book Value

Annual Sales
$2.35 billion
Price / Sales
2.85
Cash Flow
$0.81 per share
Price / Cash Flow
35.60
Book Value
$2.38 per share
Price / Book
12.05

Miscellaneous

Outstanding Shares
233,310,000
Free Float
205,875,000
Market Cap
$6.69 billion
Optionable
Optionable
Beta
2.44

Social Links

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (NYSE:HIMS) was last updated on 10/2/2026 by MarketBeat.com Staff.
From Our Partners